A “molecular butron” that solves the parasite resistance to certain drugs are tested successfully.
Tested with success a molecular butron ” which fixes the parasite resistance to certain drugs. the technique developed by scientists of the research network of tropical diseases (RICET) can be applied to multiple diseases. Spain, July 2012.- despite the great advances in Immunology and new vaccines, the treatment of tropical diseases remains essentially based on the chemotherapy, which is seriously threatened by the price of drugs, major side effects and increasing the development of resistance. According to researcher RICET, Dr. Luis Rivas, the development of new drugs for these diseases is unattractive for the pharmaceutical industry, due to the low return on economic benefits. Faced with this situation, the World Health Organization (ONS) recommends extend the effective life of the already existing drugs and delay everything the resistances that parasites just developing medicines. Precisely with this ultimate goal from RICET have developed molecular butron procedure ”. El butrón molecular” consiste en crear una combinación medicamento y un péptido derivado de una proteína del VIH denominada Tat. This peptide drug combination is capable of mocking ” the mechanism usually used by the parasite medications do not enter the interior of the cell and can attack you. The entry of a drug into a cell can be performed by two mechanisms. One is to simply pass through the membrane of the cell, if this is sufficiently permeable to be be transferred....
Read More